glp 1 pharma companies A $60 billion industry just found its next growth lever. ๐ With the expiry of a key patent on March 20, 2026, Indian majors are launching generic weight-loss and diabetes drugs Latin America Glucagon-like Peptide-1 (GLP-1)
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 28 - Nov 2





















